NASDAQ: XERS
Xeris Biopharma Holdings Inc Stock Ownership - Who owns Xeris Biopharma Holdings?

Insider buying vs selling

Have Xeris Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Beth HechtCLO;Sec2026-10-0116,666$9.41
$156.79kSell
Kevin McCullochCOO;Pres2026-10-0115,000$9.41
$141.12kSell
Steven PieperCFO2026-10-015,000$9.41
$47.04kSell
Kevin McCullochCOO;Pres2026-09-2825,000$10.00
$250.00kSell
Kevin McCullochCOO;Pres2026-09-0115,000$8.49
$127.31kSell
Steven PieperCFO2026-09-015,000$8.50
$42.50kSell
Beth HechtCLO;Sec2026-09-0116,666$8.49
$141.43kSell
Steven PieperCFO2026-08-125,000$8.50
$42.50kSell
Kevin McCullochCOO;Pres2026-08-0315,000$8.02
$120.24kSell
Beth HechtCLO;Sec2026-08-0316,666$8.01
$133.56kSell

1 of 6

XERS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XERS insiders and whales buy or sell their stock.

XERS Shareholders

What type of owners hold Xeris Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC2.97%5,413,284$55.05MInsider
Paul R. Edick2.12%3,868,354$39.34MInsider
John Patrick Shannon Jr.1.59%2,898,933$29.48MInsider
James E. Flynn1.29%2,355,136$23.95MInsider
Palmetto Partners Ltd1.16%2,110,061$21.46MInsider
Kevin McCulloch0.91%1,651,208$16.79MInsider
Steven Pieper0.74%1,351,053$13.74MInsider
Beth Hecht0.61%1,111,130$11.30MInsider
Steven Prestrelski0.39%719,780$7.32MInsider
John Johnson0.39%707,276$7.19MInsider

1 of 3

XERS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XERS0.06%13.40%Net SellingNet Selling
PGEN0.04%81.77%Net SellingNet Selling
VIR0.09%30.90%Net Selling
AGIO0.11%32.66%Net SellingNet Buying
MESO0.00%19.07%Net Buying

Xeris Biopharma Holdings Stock Ownership FAQ

Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings (NASDAQ: XERS) is owned by 0.06% institutional shareholders, 13.40% Xeris Biopharma Holdings insiders, and 86.54% retail investors. Redmile Group LLC is the largest individual Xeris Biopharma Holdings shareholder, owning 5.41M shares representing 2.97% of the company. Redmile Group LLC's Xeris Biopharma Holdings shares are currently valued at $56.03M.

If you're new to stock investing, here's how to buy Xeris Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.